Related Experiment Video
Updated: Dec 21, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Contemporary Management of Acute Lower Limb Ischemia: Determinants of Treatment Choice
1Department of Surgery, Provincial Specialty Hospital in Wloclawek, 87-800 Wloclawek, Poland.
Insights
Treatment decisions for acute lower limb ischemia (ALI) depend on factors like severity and cause. While surgery is common, endovascular approaches require fewer reinterventions, but have higher mortality.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Background:
- The management of acute lower limb ischemia (ALI) involves a choice between surgical and endovascular interventions.
- The optimal treatment strategy for ALI remains a subject of ongoing debate.
- Endovascular techniques are increasingly utilized, necessitating a clear understanding of treatment selection factors.
Purpose of the Study:
- To identify key factors influencing the choice between surgical and endovascular treatment for ALI.
- To analyze patient characteristics and outcomes associated with different treatment modalities.
- To inform clinical decision-making and potentially refine existing ALI classification systems.
Main Methods:
- Retrospective analysis of 307 patients with ALI, including 209 with thrombosis.
- Evaluation of patient demographics, clinical presentation, and procedural choices.
- Statistical analysis to determine factors associated with treatment selection and patient outcomes.
Main Results:
- Surgery was performed in 52.4% of patients.
- Surgical intervention was favored in cases of embolic ALI, severe ischemia, and concurrent cancer.
- Tibial artery involvement was associated with a lower likelihood of surgical treatment.
- Complication and amputation rates were similar between groups.
- Endovascular treatment led to higher reintervention rates.
- Six-month mortality was significantly higher in the surgically treated group.
Conclusions:
- Ischemia severity, presence of embolus, concurrent cancer, and lesion location are critical determinants for ALI treatment selection.
- The Rutherford classification may require modification to better guide decisions in severe ALI cases.
- Further research is needed to optimize treatment pathways for ALI patients.
Abstract:
The role of endovascular procedures in the treatment of acute lower limb ischemia (ALI) is expanding. For treatment, the choice between surgical or endovascular is still debated. The aim of this study was to identify factors that determine the selection of treatment. This study included 307 ALI patients (209 with thrombosis). Patient details, factors affecting the procedure choice, and outcomes were analyzed. The majority of patients were operated on (52.4%). Surgery was more frequent in embolic patients with embolus (odds ratio (OR) 33.85; 95% confidence interval (CI) 6.22-184.19, p < 0.0001), severe ischemia (OR 1.79; 95% CI 1.2-2.66, p = 0.0041), and active cancer (OR 4.99; 95% CI 1.26-19.72, p = 0.02). Tibial arteries involvement was negatively related to surgery (OR 0.25; 95% CI 0.06-0.95, p = 0.04). The complications and amputation rates were comparable. Reinterventions were more common in the endovascular group (19 (20.2%) vs. 17 (8.9%), p = 0.007). The six-month mortality was higher in the operated patients (12.6% vs. 3.2%, respectively, p = 0.001). The determinants of the treatment path are ischemia severity, concurrent cancer, embolus, and peripheral lesion location. Modification of the Rutherford acute lower limb ischemia classification is required to improve the decision-making in patients with profound ischemia.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Angina IV: Management
Acute Coronary Syndrome I: Introduction

